Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
N. Mishra, S. Kumar, S. Singh, T. Bansal, N. Jain, S. Saluja, J. K. Palanichamy, R. A. Mir, S. Sinha, K. Luthra
This study shows that HIV-1 broadly neutralizing antibodies and plasma from HIV-1 infected children can cross-neutralize SARS-CoV-2 by targeting conserved epitopes and glycans on the spike protein.
bioRxiv · Dec 9, 2020Immunology